Patents by Inventor Robert Jiang

Robert Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted heterocyclic compounds
    Patent number: 7026321
    Abstract: Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: April 11, 2006
    Assignee: CV Therapeutics, Inc.
    Inventors: Robert Jiang, Tim Marquart, Jeff Zablocki, Elfatih Elzein, Venkata Palle, Prabha Ibrahim
  • ABCA-1 elevating compounds
    Patent number: 6995285
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Grant
    Filed: June 4, 2002
    Date of Patent: February 7, 2006
    Assignee: CV Therapeutics, Inc.
    Inventors: Prabha N. Ibrahim, Robert Jiang, Christopher Morrison, Kevin Shenk, Jeff A. Zablocki
  • ABCA-1 ELEVATING COMPOUNDS
    Publication number: 20050267215
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Application
    Filed: June 4, 2002
    Publication date: December 1, 2005
    Inventors: Prabha Ibrahim, Robert Jiang, Christopher Morrison, Kevin Shenk, Jeff Zablocki
  • ABCA-1 elevating compounds
    Patent number: 6900219
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: May 31, 2005
    Assignee: CV Therapeutics, Inc.
    Inventors: Prabha Ibrahim, Michael Campbell, Robert Jiang, Christopher Morrison, Kevin Shenk, William Shirley, Jeff Zablocki, Dmitry Koltun, Reina Natero
  • Substituted heterocyclic compounds
    Publication number: 20040186109
    Abstract: Disclosed are novel heterocyclic derivatives, useful for the treatment of various disease states, in particular cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease, and myocardial infarction. The compounds are also useful in the treatment of diabetes.
    Type: Application
    Filed: January 16, 2004
    Publication date: September 23, 2004
    Inventors: Robert Jiang, Tim Marquart, Jeff Zablocki, Elfatih Elzein, Venkata Palle, Prabha Ibrahim
  • ABCA-1 elevating compounds
    Patent number: 6713650
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Grant
    Filed: December 5, 2001
    Date of Patent: March 30, 2004
    Inventors: Prabha N. Ibrahim, Robert Jiang, Christopher Morrison, Kevin Shenk, Jeff A. Zablocki, Richard Lawn
  • Partial and full agonists of A1 adenosine receptors
    Publication number: 20030232783
    Abstract: Disclosed are novel compounds that are partial and full A1 adenosine receptor agonists, useful for treating various disease states, in particular tachycardia and atrial flutter, angina, myocardial infarction and hyperlipidemia.
    Type: Application
    Filed: February 18, 2003
    Publication date: December 18, 2003
    Inventors: Prabha Ibrahim, Elfatih Elzein, Kevin Shenk, Robert Jiang, Jeff Zablocki, Xiaofen Li, Christopher Morrison, Thao Perry, Dengming Xiao
  • ABCA-1 elevating compounds
    Publication number: 20030220356
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Application
    Filed: April 4, 2003
    Publication date: November 27, 2003
    Inventors: Prabha Ibrahim, Michael Campbell, Robert Jiang, Christopher Morrison, Kevin Shenk, William Shirley, Jeff Zablocki, Dmitry Koltun, Reina Natero
  • ABCA-1 Elevating compounds
    Publication number: 20020082257
    Abstract: The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
    Type: Application
    Filed: December 5, 2001
    Publication date: June 27, 2002
    Inventors: Prabha N. Ibrahim, Robert Jiang, Christopher Morrison, Kevin Shenk, Jeff A. Zablocki, Richard Lawn